SCHEMBL2995989

SCHEMBL2995989

CCOc1ccc2c(c1)c(CC(=O)Nc1ccncc1)c(C(F)(F)F)n2Cc1ccc(Cl)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PLA2G2A P14555 2/20 0.48
▸ PTGS2 P35354 8/20 0.46
▸ NPC1 O15118 1/20 0.45
▸ RAB9A P51151 1/20 0.45
▸ ALOX5 P09917 1/20 0.43
▸ ALOX5AP P20292 1/20 0.43
▸ MAPT P10636 4/20 0.42
▸ KMT2A Q03164 2/20 0.42
▸ LMNA P02545 2/20 0.42
▸ MEN1 O00255 1/20 0.42
▸ RGS12 O14924 1/20 0.42
▸ ALDH1A1 P00352 1/20 0.42
▸ CYP1A2 P05177 1/20 0.42
▸ CYP3A4 P08684 1/20 0.42
▸ CYP2C9 P11712 1/20 0.42
▸ PKM P14618 1/20 0.42
▸ TSHR P16473 1/20 0.42
▸ NFKB1 P19838 1/20 0.42
▸ MAPK1 P28482 1/20 0.42
▸ CYP2C19 P33261 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3001953 0.92 PLA2G2A (0.58) PLA2G2APTGS2MAPTKMT2ALMNA
SCHEMBL16222857 0.89 PLA2G2A (0.50) PLA2G2APTGS2NPC1RAB9AALOX5
SCHEMBL3010246 0.87 RAB9A (0.49) PLA2G2APTGS2NPC1RAB9AALOX5
SCHEMBL3010179 0.86 RAB9A (0.50) PLA2G2APTGS2NPC1RAB9AMAPT
SCHEMBL2993129 0.85 FAAH (0.51) PLA2G2AALOX5ALOX5APMAPTLMNA
SCHEMBL4378390 0.82 FAAH (0.48) ALOX5ALOX5APMAPTKMT2AMEN1
SCHEMBL3007091 0.78 FAAH (0.48) PLA2G2AMAPTKMT2ALMNAMEN1
SCHEMBL4095937 0.77 FAAH (0.53) PLA2G2AALOX5ALOX5APMAPT
SCHEMBL4083537 0.77 FAAH (0.54) ALOX5ALOX5APMAPTLMNA
SCHEMBL4100733 0.76 FAAH (0.55) PLA2G2AALOX5ALOX5APMAPTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100197708-A1 INDOLE COMPOUNDS WELLS FARGO BANK, NATIONAL ASSOCIATION 2010-08-05 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100197708-A1 INDOLE COMPOUNDS IDO1, IDO2, TPH2 PLA2G2A 3285/4885PTGS2 45/4885NPC1 2681/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback